Page 24 - TRAMES-BP®
P. 24
Asenapine improved depressive
symptoms in manic/mixed patients
Patients with baseline MADRS ≥20
LS mean (±SE) change from
baseline MADRS total score
Asenapine (n=45)
Placebo (n=33)
Olanzapine (n=54)
**
†
**
Szegedi et al. BMC Psychiatry 2011;11:101
†
24 Post-hoc analysis; **p≤0.01 vs placebo; p=0.02 vs olanzapine
symptoms in manic/mixed patients
Patients with baseline MADRS ≥20
LS mean (±SE) change from
baseline MADRS total score
Asenapine (n=45)
Placebo (n=33)
Olanzapine (n=54)
**
†
**
Szegedi et al. BMC Psychiatry 2011;11:101
†
24 Post-hoc analysis; **p≤0.01 vs placebo; p=0.02 vs olanzapine
